Creatine Kinase MB Type I

<strong>Creatine Kinase MB Type I</strong>_x000D_ <strong>Catalog number:</strong> B2012182_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 100 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> &gt; 1.0 mg/mL_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> CK-MB type I_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Kurapati R, Soos MP. CPK-MB 2022 Apr 21. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–._x000D_ 2: Chaitman BR, Alexander KP, Cyr DD, Berger JS, Reynolds HR, Bangalore S, Boden WE, Lopes RD, Demkow M, Piero Perna G, Riezebos RK, McFalls EO, Banerjee S, Bagai A, Gosselin G, O'Brien SM, Rockhold FW, Waters DD, Thygesen KA, Stone GW, White HD, Maron DJ, Hochman JS; ISCHEMIA Research Group. Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons Circulation. 2021 Feb 23;143(8):790-804._x000D_ 3: Mastro F, Guida P, Scrascia G, Rotunno C, Amorese L, Carrozzo A, Capone G, Paparella D. Cardiac troponin I and creatine kinase-MB release after different cardiac surgeries J Cardiovasc Med (Hagerstown). 2015 Jun;16(6):456-64._x000D_ 4: Son S, Yoo SA, Nam K, Oh S, Lee KM, Yi JY, Shin I. Brain type of creatine kinase induces doxorubicin resistance via TGF-β signaling in MDA-MB-231 breast cancer cells Anim Cells Syst (Seoul). 2022 Aug 31;26(5):203-213._x000D_ 5: Ye XD, He Y, Wang S, Wong GT, Irwin MG, Xia Z. Heart-type fatty acid binding protein (H-FABP) as a biomarker for acute myocardial injury and long-term post-ischemic prognosis Acta Pharmacol Sin. 2018 Jul;39(7):1155-1163._x000D_ 6: Fan J, Ma J, Xia N, Sun L, Li B, Liu H. Clinical Value of Combined Detection of CK-MB, MYO, cTnI and Plasma NT-proBNP in Diagnosis of Acute Myocardial Infarction Clin Lab. 2017 Mar 1;63(3):427-433._x000D_ 7: Jo MS, Lee J, Kim SY, Kwon HJ, Lee HK, Park DJ, Kim Y. Comparison between creatine kinase MB, heart-type fatty acid-binding protein, and cardiac troponin T for detecting myocardial ischemic injury after cardiac surgery Clin Chim Acta. 2019 Jan;488:174-178._x000D_ 8: Jansson E, Sylvén C. Creatine kinase MB and citrate synthase in type I and type II muscle fibres in trained and untrained men Eur J Appl Physiol Occup Physiol. 1985;54(2):207-9._x000D_ 9: Hsu JT, Chung CM, Chu CM, Lin YS, Pan KL, Chang JJ, Wang PC, Chang ST, Yang TY, Jang SJ, Yang TH, Hsiao JF. Predictors of Left Ventricle Remodeling: Combined Plasma B-type Natriuretic Peptide Decreasing Ratio and Peak Creatine Kinase-MB Int J Med Sci. 2017 Jan 15;14(1):75-85._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/20825920">10: Orak M, Ustündağ M, Güloğlu C, Ozhasenekler A, Alyan O, Kale E. The role of the heart-type fatty acid binding protein in the early diagnosis of acute coronary syndrome and its comparison with troponin I and creatine kinase-MB isoform Am J Emerg Med. 2010 Oct;28(8):891-6. </a>_x000D_ _x000D_ <strong>Products Related to Creatine Kinase MB Type I can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>